Cancer stem cell phosphatases.
DUSP6
PP2A
PTEN
PTP1B
SHP2
WIP1
Journal
The Biochemical journal
ISSN: 1470-8728
Titre abrégé: Biochem J
Pays: England
ID NLM: 2984726R
Informations de publication
Date de publication:
30 07 2021
30 07 2021
Historique:
received:
08
04
2021
revised:
05
07
2021
accepted:
07
07
2021
entrez:
28
7
2021
pubmed:
29
7
2021
medline:
30
11
2021
Statut:
ppublish
Résumé
Cancer stem cells (CSCs) are involved in the initiation and progression of human malignancies by enabling cancer tissue self-renewal capacity and constituting the therapy-resistant population of tumor cells. However, despite the exhausting characterization of CSC genetics, epigenetics, and kinase signaling, eradication of CSCs remains an unattainable goal in most human malignancies. While phosphatases contribute equally with kinases to cellular phosphoregulation, our understanding of phosphatases in CSCs lags severely behind our knowledge about other CSC signaling mechanisms. Many cancer-relevant phosphatases have recently become druggable, indicating that further understanding of the CSC phosphatases might provide novel therapeutic opportunities. This review summarizes the current knowledge about fundamental, but yet poorly understood involvement of phosphatases in the regulation of major CSC signaling pathways. We also review the functional roles of phosphatases in CSC self-renewal, cancer progression, and therapy resistance; focusing particularly on hematological cancers and glioblastoma. We further discuss the small molecule targeting of CSC phosphatases and their therapeutic potential in cancer combination therapies.
Identifiants
pubmed: 34319405
pii: 229413
doi: 10.1042/BCJ20210254
doi:
Substances chimiques
Phosphoric Monoester Hydrolases
EC 3.1.3.2
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
2899-2920Informations de copyright
© 2021 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.